Home/Filings/4/0001415889-24-003806
4//SEC Filing

Murphy Sean 4

Accession 0001415889-24-003806

CIK 0001826667other

Filed

Feb 13, 7:00 PM ET

Accepted

Feb 14, 6:17 PM ET

Size

9.3 KB

Accession

0001415889-24-003806

Insider Transaction Report

Form 4
Period: 2024-02-12
Murphy Sean
DirectorChief Manuf, Strategy&Bus Dev.
Transactions
  • Award

    Common Stock

    2024-02-12+34,14450,788 total
  • Award

    Employee Stock Option (right to buy)

    2024-02-12+105,000105,000 total
    Exercise: $9.50Exp: 2034-02-11Common Stock (105,000 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    357,535
  • Common Stock

    (indirect: By Sean E Murphy TTEE U/A 2/4/2004)
    167,732
Footnotes (3)
  • [F1]Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU Award vest in four equal annual installments commencing on February 12, 2024, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.
  • [F2]The Reporting Person's spouse has voting and investment discretion with respect to the shares held directly by Murphy Family Trust 2012 and thus the Reporting Person may be deemed to have beneficial ownership of the shares held directly by Murphy Family Trust 2012.
  • [F3]One-fourth (1/4th) of the shares subject to the option shall vest on the one-year anniversary of the vesting commencement date of February 12, 2024, and 1/36th of the remaining shares shall vest each month thereafter, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.

Issuer

TriSalus Life Sciences, Inc.

CIK 0001826667

Entity typeother

Related Parties

1
  • filerCIK 0001685042

Filing Metadata

Form type
4
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 6:17 PM ET
Size
9.3 KB